Frequency Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview

Korro Bio

12/11/2021 13:56

* Frequency Therapeutics Inc  FREQ.OQ   FREQ.O  is expected
to show a fall in quarterly revenue when it reports  results on
November 15 (estimated). 
* The Lexington, Massachusetts-based company is expected to
report  a 78.9% decrease in revenue to $2.378 million from
$11.25 million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Frequency Therapeutics
Inc is for a loss of 57 cents per share. For the same quarter
last year, the company reported a loss of 16 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $13​, about 50.5% above​ its last closing
price of $6.43. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.51       -0.51      -0.52     Missed  -2.3
 Mar. 31 2021  -0.28       -0.28      -0.60     Missed  -116.9
 Dec. 31 2020  -0.26       -0.25      -0.30     Missed  -17.8​
 Sep. 30 2020  -0.27       -0.28      -0.16     Beat    42.6
 ​​Jun.        -0.19       -0.18      -0.19     Missed  -3.1
 30 2020                                                
 Mar. 31 2020  -0.18       -0.17      -0.16     Beat    7.5​
 Dec. 31 2019              0.10       -0.19     Missed  -287.2
 Sep. 30 2019  -0.68       -0.68      -0.73     Missed  -7.4
 This summary was machine generated November 12 at 13:56 GMT. 
All figures in US dollars  unless otherwise stated